Eddy Mizrahi

A Dose of Trouble: A Case of Furosemide Exacerbating Amiodarone-Induced Hypothyroidism

Muneeba Ali, Enad Haddad, W Naqvi, Afzal, MD, Ayesha et autres

Heart failure with reduced ejection fraction is a clinical condition that often requires the concurrent use of multiple medications. Unfortunately, cross reactivity between multiple drugs occurs frequently. Today, we present the case of a 79-year-old male with heart failure and atrial fibrillation …

us (code pays fourni par la source)

26-A-21557-ACC ASSOCIATION OF WEEKEND ADMISSION WITH CLINICAL OUTCOMES IN ACUTE CORONARY SYNDROME: INSIGHTS FROM THE NATIONAL INPATIENT SAMPLE (NIS) DATABASE, 2019-2022

Sudeep Nugooru, Enad Haddad, Eddy Mizrahi

us (code pays fourni par la source)

Congenital Left Atrial Mitral Accessory Chord With Accessory Mitral Valve Tissue Causing Dual-Valve Regurgitation

Fahad Waqar, Eddy Mizrahi, Andrew Fireman, Robert Scott Watson et autres

BACKGROUND: Left atrial mitral valve (MV) accessory chord and accessory MV tissue are rare congenital anomalies that may mimic more common pathologies. CASE SUMMARY: A 30-year-old man presented with dyspnea, weight loss, and an outpatient transthoracic echocardiogram concerning for infective endocarditis. Transesophageal …

us (code pays fourni par la source)

A DOSE OF TROUBLE: A CASE OF FUROSEMIDE TRIGGERING AMIODARONE-INDUCED HYPOTHYROIDISM

Muneeba Ali, Eddy Mizrahi

UNMASKING A SILENT THREAT: LATE PROSTHETIC VALVE DEHISCENCE FROM UNDIAGNOSED CHRONIC AORTIC DISSECTION

Mohammed Sabri, SHAYAN KHAN, Shaival Sharma, Eddy Mizrahi

Abstract FR487: Impact of Hypertension on Outcomes in Cardiac Amyloidosis: Trends in Heart Failure, Mortality, and Arrhythmias Compared to Non-Hypertensive Cases

Muhammad Sabri, Shaival Sharma, Rachel Ramirez, Eddy Mizrahi et autres

Introduction: Patients with cardiac amyloidosis (CA) may have concomitant hypertension (HTN) that has an impact on their long-term mortality and morbidity. However, there is seldom evidence of HTN cardiovascular outcomes on CA. Hypothesis: We compared cardiovascular outcomes of HTN in patients with …

us (code pays fourni par la source)

Abstract FR494: Impact Of Systemic Hypertension On Cardiovascular Outcomes and Mortality in Cardiac Sarcoidosis Patients: A Real-World Analysis

Muhammad Sabri, Nimra Klair, Eddy Mizrahi, Robert Watson et autres

Introduction: Systemic hypertension (HTN) is prevalent in cardiac sarcoidosis (CS) and may influence long-term outcomes, particularly in patients receiving corticosteroids and calcineurin inhibitors. These treatments can increase susceptibility to elevated blood pressure and HTN crises, further complicating the management of CS. Hypothesis: …

us (code pays fourni par la source)

Abstract FR446: FLUDROCORTISONE VS MIDODRINE FOR ORTHOSTATIC HYPOTENSION: A RETROSPECTIVE COHORT STUDY

Muhammad Sabri, Shayan Khan, Eddy Mizrahi, Donald C. Haas

Introduction: Orthostatic hypotension (OH) is a debilitating condition commonly observed in patients with impaired vascular tone upon positional changes, often due to neurogenic disorders, liver disease, hypovolemia, or advanced HF. While fludrocortisone has been associated with adverse outcomes—particularly HF-related complications—compared to midodrine …

us (code pays fourni par la source)

Abstract FR530: Comparative Impact of Hypertension on Cardiovascular Outcomes in Non-Ischemic Versus Ischemic Cardiomyopathy: A Retrospective Cohort Study

Muhammad Sabri, Shayan Khan, Dylan Deyar, Eddy Mizrahi et autres

Introduction: Hypertension (HTN) is prevalent in non-ischemic cardiomyopathy (NICM) and a known risk factor for ischemic cardiomyopathy (ICM), independently contributing to adverse cardiovascular outcomes. However, limited data exist comparing its impact on outcomes between NICM and ICM populations. Hypothesis: This study aims …

us (code pays fourni par la source)

Abstract FR531: Outcomes in Hypertensive Patients With Systolic Versus Diastolic Heart Failure: A Retrospective Cohort Study

Muhammad Sabri, Shayan Khan, Dylan Deyar, Eddy Mizrahi et autres

Introduction: Hypertension (HTN) is a cmorbidity and a contributor to both systolic and diastolic heart failure (HF). However, limited research exists comparing HTN outcome in patient with systolic versus diastolic HF. Hypothesis: This study aims to compare the impact of HTN on …

us (code pays fourni par la source)

Abstract TAC108: Comparative Effectiveness Of Mineralocorticoid Receptor Antagonists And Thiazide Diuretics In Essential Hypertension Without Heart Failure: A Retrospective Cohort Study

Muhammad Sabri, Nimra Klair, Eddy Mizrahi, Robert A. Watson et autres

Introduction: Mineralocorticoid receptor antagonists (MRAs) are established as first-line antihypertensive agents for patients with HF or secondary hypertension (HTN) caused by hyperaldosteronism. However, their role as first-line treatment for essential HTN in patients without HF remains underexplored. Hypothesis: This study aims to …

us (code pays fourni par la source)

Abstract FR447: Cardiovascular Outcomes in Heart Failure Patients With Hypertension Versus Tobacco Use: A Retrospective Cohort Study

Muhammad Sabri, Shayan Khan, Eddy Mizrahi, Donald C. Haas

Introduction: Heart Failure (HF) patients have risk factors such as tobacco use, chronic kidney disease (CKD), and hypertension (HTN), all linked to poor cardiovascular outcomes. While CKD and DM are recognized as equivalent to atherosclerotic cardiovascular disease (ASCVD). HTN and tobacco use …

us (code pays fourni par la source)